About Shanghai Baixin'an Biotechnology
Shanghai Baixin'an Biotechnology is a company based in Pudong (China) founded in 2014.. Shanghai Baixin'an Biotechnology has raised $15.79 million across 2 funding rounds from investors including Shanghai Zhangjiang Technology Venture Capital, CD Capital and Qianhai Ark Asset Management. The company has 63 employees as of December 31, 2024. Shanghai Baixin'an Biotechnology operates in a competitive market with competitors including Silk Road Medical, Lifetech Scientific Corporation, HDL Therapeutics, Supira Medical and Transvascular, among others.
- Headquarter Pudong, China
- Employees 63 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Shanghai Bio-Heart Biological Technology Co., Ltd. Class H
-
Annual Revenue
$0 (USD)0as on Dec 31, 2024
-
Net Profit
$-12.28 M (USD)50.94as on Dec 31, 2024
-
EBITDA
$-7.38 M (USD)63.79as on Dec 31, 2024
-
Total Equity Funding
$15.79 M (USD)
in 2 rounds
-
Latest Funding Round
$8.54 M (USD), Series B
Nov 15, 2019
- Investors
-
Employee Count
63
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Shanghai Baixin'an Biotechnology
Shanghai Baixin'an Biotechnology is a publicly listed company on the HKEX with ticker symbol 2185 in Hong Kong, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Shanghai Baixin'an Biotechnology
Shanghai Baixin'an Biotechnology has successfully raised a total of $15.79M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $8.54 million completed in November 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $8.5M
-
First Round
First Round
(01 Apr 2017)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2019 | Amount | Series B - Shanghai Baixin'an Biotechnology | Valuation | Shanghai Zhangjiang Technology Venture Capital , CD Capital |
|
| Apr, 2017 | Amount | Series A - Shanghai Baixin'an Biotechnology | Valuation | Shanghai Yuchen Mechanical and Electrical Engineering |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Shanghai Baixin'an Biotechnology
Shanghai Baixin'an Biotechnology has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Shanghai Zhangjiang Technology Venture Capital, CD Capital and Qianhai Ark Asset Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Shanghai Baixin'an Biotechnology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Shanghai Baixinan Biotechnology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Shanghai Baixin'an Biotechnology Comparisons
Competitors of Shanghai Baixin'an Biotechnology
Shanghai Baixin'an Biotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Silk Road Medical, Lifetech Scientific Corporation, HDL Therapeutics, Supira Medical and Transvascular, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of neuroprotection devices for carotid artery disease
|
|
| domain | founded_year | HQ Location |
Interventional devices for cardiovascular and vascular diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapy to reverse coronary atherosclerosis is developed using patient plasma.
|
|
| domain | founded_year | HQ Location |
Developer of ventricular assist devices for coronary intervention and cardiogenic shock
|
|
| domain | founded_year | HQ Location |
A TransAccess Catheter System that is used to deliver cells to damaged portions of the heart
|
|
| domain | founded_year | HQ Location |
Catheter ablation treatments for atrial fibrillation are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Shanghai Baixin'an Biotechnology
Frequently Asked Questions about Shanghai Baixin'an Biotechnology
When was Shanghai Baixin'an Biotechnology founded?
Shanghai Baixin'an Biotechnology was founded in 2014 and raised its 1st funding round 3 years after it was founded.
Where is Shanghai Baixin'an Biotechnology located?
Shanghai Baixin'an Biotechnology is headquartered in Pudong, China. It is registered at Pudong, Shanghai, China.
Is Shanghai Baixin'an Biotechnology a funded company?
Shanghai Baixin'an Biotechnology is a funded company, having raised a total of $15.79M across 2 funding rounds to date. The company's 1st funding round was a Series A of $7.25M, raised on Apr 01, 2017.
How many employees does Shanghai Baixin'an Biotechnology have?
As of Dec 31, 2024, the latest employee count at Shanghai Baixin'an Biotechnology is 63.
What does Shanghai Baixin'an Biotechnology do?
Shanghai Baixinan Biotechnology is the developer of the coronary stent system. The platform is developing a bioabsorbable coronary rapamycin eluting stent system by using L-polylactic acid (PLLA). The device is coated with rapamycin drug and the drug-coated polylactic acid (PDLLA) carrier. The device is inserted into the blood vessel and drug release design is released about 80 in 28 days.
Who are the top competitors of Shanghai Baixin'an Biotechnology?
Shanghai Baixin'an Biotechnology's top competitors include Silk Road Medical, Lifetech Scientific Corporation and InterShunt Technologies.
Is Shanghai Baixin'an Biotechnology publicly traded?
Yes, Shanghai Baixin'an Biotechnology is publicly traded on HKEX under the ticker symbol 2185.
Who are Shanghai Baixin'an Biotechnology's investors?
Shanghai Baixin'an Biotechnology has 5 investors. Key investors include Shanghai Zhangjiang Technology Venture Capital, CD Capital, Qianhai Ark Asset Management, BioVenture, and Shanghai Yuchen Mechanical and Electrical Engineering.
What is Shanghai Baixin'an Biotechnology's ticker symbol?
The ticker symbol of Shanghai Baixin'an Biotechnology is 2185 on HKEX.